Houston Texas Medical Center


Hospital

Location:
Houston, United States (USA)


Publications in cooperation with FAU scientists


Go to first page Go to previous page 1 of 2 Go to next page Go to last page
Sikic, D., Wirtz, R.M., Wach, S., Dyrskjot, L., Erben, P., Bolenz, C.,... Keck, B. (2019). Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts. Translational Oncology, 12(4), 661-668. https://dx.doi.org/10.1016/j.tranon.2019.01.005
Zollino, M., Zweier, C., Van Balkom, I.D., Sweetser, D.A., Alaimo, J., Bijlsma, E.K.,... Hennekam, R.C. (2019). Diagnosis and management in Pitt-Hopkins syndrome: First international consensus statement. Clinical Genetics, 95(4), 462-478. https://dx.doi.org/10.1111/cge.13506
Dalekos, G., Invernizzi, P., Nevens, F., Hans, V.V., Zigmond, E., Andrade, R.J.,... Wiese, P. (2019). Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. In JOURNAL OF HEPATOLOGY (pp. E1-E2). Vienna, AUSTRIA: AMSTERDAM: ELSEVIER SCIENCE BV.
Alexandrov, A., Köhrmann, M., Soinne, L., Tsivgoulis, G., Barreto, A.D., Demchuk, A.M.,... Schellinger, P.D. (2019). Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial. Lancet Neurology, 18(4), 338-347.
Sikic, D., Wirtz, R., Wach, S., Dyrskjot, L., Erben, P., Bolenz, C.,... Keck, B. (2018). Analysis of androgen receptor mRNA expression in urothelial carcinoma of the bladder. (pp. 70-70).
Johnston, J.J., Van Der Smagt, J.J., Rosenfeld, J.A., Pagnamenta, A.T., Alswaid, A., Baker, E.H.,... Biesecker, L.G. (2018). Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. Genetics in Medicine. https://dx.doi.org/10.1038/gim.2017.249
Kremer, A., Bowlus, C.L., Neff, G.W., Aspinall, R., Galambos, M.R., Goel, A.,... Boudes, P. (2018). Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study. (pp. 1464A-1465A).
Hirschfield, G., Boudes, P., Bowlus, C., Gitlin, N., Michael, G., Harrison, S.,... Jones, D. (2018). Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study. In JOURNAL OF HEPATOLOGY (pp. S105-S106). Paris, FR: AMSTERDAM: ELSEVIER SCIENCE BV.
Kawabe, H., Mitkovski, M., Kaeser, P.S., Hirrlinger, J., Opazo, F., Nestvogel, D.,... Brose, N. (2017). ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. Journal of Cell Biology, 216(4), 1143-1161. https://dx.doi.org/10.1083/jcb.201606086
Heinemann, F.M., Jindra, P.T., Bockmeyer, C.L., Zeuschner, P., Wittig, J., Hoeflich, H.,... Becker, J.U. (2017). Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Scientific Reports, 7(1), 14554. https://dx.doi.org/10.1038/s41598-017-14674-5
Stankiewicz, P., Khan, T.N., Szafranski, P., Slattery, L., Streff, H., Vetrini, F.,... Yang, Y. (2017). Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features. American Journal of Human Genetics, 101(4), 503-515. https://dx.doi.org/10.1016/j.ajhg.2017.08.014
Krupar, R., Hautmann, M.G., Pathak, R.R., Varier, I., Mclaren, C., Gaag, D.,... Sikora, A.G. (2017). Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma. American Journal of Pathology. https://dx.doi.org/10.1016/j.ajpath.2017.09.013
Hahn, F., Schmalen, A., Setz, C., Friedrich, M., Schlößer, S., Kölle, J.,... Schubert, U. (2017). Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner. PLoS ONE, 12(4). https://dx.doi.org/10.1371/journal.pone.0174254
Jones, D., Boudes, P.F., Swain, M.G., Bowlus, C.L., Galambos, M.R., Bacon, B.R.,... Hirschfield, G.M. (2017). Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. Lancet Gastroenterology and Hepatology, 2(10), 716-726. https://dx.doi.org/10.1016/S2468-1253(17)30246-7
Guermazi, A., Kalsi, G., Niu, J., Crema, M.D., Copeland, R.O., Orlando, A.,... Roemer, F. (2017). Structural effects of intra-articular TGF-β1 in moderate to advanced knee osteoarthritis: MRI-based assessment in a randomized controlled trial. BMC musculoskeletal disorders, 18(1), 461. https://dx.doi.org/10.1186/s12891-017-1830-8
Dixon, S.C., Nagle, C.M., Thrift, A.P., Pharoah, P.D.P., Pearce, C.L., Zheng, W.,... Webb, P.M. (2016). Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology, 45(3), 884-95. https://dx.doi.org/10.1093/ije/dyw158
Gingras, M.-C., Covington, K.R., Chang, D.K., Donehower, L.A., Gill, A.J., Ittmann, M.M.,... Pilarsky, C. (2016). Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Reports, 14(4), 907-19. https://dx.doi.org/10.1016/j.celrep.2015.12.005
Bailey, P., Chang, D.K., Nones, K., Johns, A.L., Patch, A.-M., Gingras, M.-C.,... Pilarsky, C. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52. https://dx.doi.org/10.1038/nature16965
Kuechler, A., Willemsen, M.H., Albrecht, B., Bacino, C.A., Bartholomew, D.W., Van Bokhoven, H.,... Wieczorek, D. (2015). De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum. Human genetics, 134(1), 97-109. https://dx.doi.org/10.1007/s00439-014-1498-1
Goebell, P., Kamat, A.M., Sylvester, R.J., Black, P., Droller, M., Godoy, G.,... Schmitz-Draeger, B.J. (2014). Assessing the quality of studies on the diagnostic accuracy of tumor markers. Urologic Oncology-Seminars and Original Investigations, 32(7), 1051-60. https://dx.doi.org/10.1016/j.urolonc.2013.10.003

Last updated on 2018-23-01 at 09:16